TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 19 filers reported holding TREVI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,214 | -14.4% | 22,575 | -6.2% | 0.00% | – |
| Q2 2023 | $57,491 | +310.0% | 24,055 | +217.3% | 0.00% | – |
| Q1 2023 | $14,023 | +135.0% | 7,580 | +145.2% | 0.00% | – |
| Q4 2022 | $5,966 | -14.8% | 3,091 | -27.7% | 0.00% | – |
| Q3 2022 | $7,000 | -46.2% | 4,277 | -10.4% | 0.00% | – |
| Q2 2022 | $13,000 | +225.0% | 4,771 | +193.8% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 1,624 | -68.6% | 0.00% | – |
| Q3 2021 | $7,000 | +40.0% | 5,173 | +142.1% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 2,137 | -10.1% | 0.00% | – |
| Q1 2021 | $6,000 | +200.0% | 2,378 | +339.6% | 0.00% | – |
| Q1 2020 | $2,000 | -71.4% | 541 | -65.7% | 0.00% | – |
| Q3 2019 | $7,000 | -50.0% | 1,577 | -17.9% | 0.00% | – |
| Q2 2019 | $14,000 | – | 1,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |